60Angeliki Cooney has been a pivotal figure in the life sciences industry for over twenty years, based out of Wynantskill, NY. Her extensive career is marked by her commitment to advancing the accessibility and development of innovative treatments for chronic illnesses, rare diseases, and cancers.
Throughout her professional journey, Angeliki has specialized in advising biopharmaceutical firms, focusing on digital transformation, omnichannel customer engagement, and strategic commercial operations. Her noteworthy achievements include developing several proprietary software-as-a-service (SaaS) products tailored for the life sciences industry, earning her three patents.
In her recent role as Senior Vice President of Life Sciences at Avenga, Angeliki led the company's strategic initiatives to expand into the U.S. market. Avenga, a leading global consulting and technology firm, works with prominent entities in the pharmaceutical and biotechnology sectors. Her strategic vision and leadership significantly broadened the company's client base, establishing a solid footprint in the U.S. market.
Before her tenure at Avenga, she was the Principal Group Lead of Commercial Excellence at Axtria. In this role, she managed a broad client portfolio across the U.S. and Europe, significantly enhancing the company's market share through her innovative commercial strategies and engagement models.
Her previous experience includes a significant stint as Senior Director of Life Sciences Consulting at Gartner, where she facilitated enhanced integration of business strategies with I.T. solutions for life sciences clients. Angeliki also held influential roles at notable companies like New York Life Insurance, IMS Health, and Z.S. Associates, where she enhanced digital and analytical capabilities to improve healthcare outcomes and business results.
Angeliki's interest in pharmaceuticals began in her youth, sparked by an internship at her godfather's European pharmacy. This early exposure fueled her passion for the field, leading her to pursue advanced degrees—an MBA from Harvard Business School and an M.S. in Chemical Engineering from the University of Patra, Greece.
Outside of her professional commitments, she is an avid skier, sharing this passion with her family, inspired by her son's enthusiasm for the sport. She is deeply connected to her Greek roots, actively supporting relief efforts during the Syrian refugee crisis and frequently visiting Greece to reconnect with family and enjoy the country's rich landscapes. Angeliki Cooney continues to influence the life sciences industry through her innovative approaches and strategic insights, shaping the future of healthcare and treatment accessibility.